{"id":"dex-infusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Immunosuppression / increased infection risk"},{"rate":null,"effect":"Hypertension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone is a synthetic glucocorticoid that binds to glucocorticoid receptors in the cytoplasm, translocates to the nucleus, and modulates gene transcription to suppress pro-inflammatory cytokine production, reduce immune cell activation, and decrease vascular permeability. The intravenous infusion formulation allows rapid systemic delivery for acute inflammatory or immunological conditions.","oneSentence":"Dexamethasone infusion delivers a corticosteroid systemically to reduce inflammation and suppress immune responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:44:28.378Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute inflammation and immune suppression (specific indications not detailed in available information)"}]},"trialDetails":[{"nctId":"NCT07497009","phase":"NA","title":"Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial.","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-12-23","conditions":"Neurocognitive Function of Elderly Patients Post Operation","enrollment":30},{"nctId":"NCT02773030","phase":"PHASE1, PHASE2","title":"A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celgene","startDate":"2016-10-14","conditions":"Multiple Myeloma","enrollment":466},{"nctId":"NCT07475156","phase":"PHASE4","title":"The Effect of Dexmedetomidine Infusion Alone Versus the Combination of Dexmedetomidine and Melatonin on Reduction of Post-operative Delirium (POD) After Open Brain Surgeries","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-08-01","conditions":"Post Operative Delerium","enrollment":100},{"nctId":"NCT07443085","phase":"PHASE2","title":"Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery","status":"RECRUITING","sponsor":"Benha University","startDate":"2026-02-26","conditions":"Delirium - Postoperative","enrollment":75},{"nctId":"NCT06406829","phase":"NA","title":"Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-09","conditions":"Postoperative Pain, Analgesia, Supratentorial Brain Tumor","enrollment":2000},{"nctId":"NCT07398066","phase":"NA","title":"DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)","status":"NOT_YET_RECRUITING","sponsor":"University of Malaya","startDate":"2026-07-22","conditions":"Neurosurgery, Brain Cancer, Meningioma","enrollment":60},{"nctId":"NCT07231926","phase":"NA","title":"Intrathecal Morphine for Recovery and Outcomes After VATS","status":"RECRUITING","sponsor":"Ataturk University","startDate":"2025-12-01","conditions":"Postoperative Pain Management in Video-Assisted Thoracoscopic Surgery","enrollment":52},{"nctId":"NCT07385131","phase":"","title":"Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-10-08","conditions":"Inflammatory Bowel Disease (IBD), CD - Crohn's Disease, UC - Ulcerative Colitis","enrollment":300},{"nctId":"NCT04681105","phase":"PHASE1","title":"Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2020-11-18","conditions":"Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm","enrollment":13},{"nctId":"NCT07350668","phase":"PHASE3","title":"Opioid-Free vs Opioid-Based Anesthesia for Nasal Surgeries","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-01-01","conditions":"Postoperative Pain","enrollment":60},{"nctId":"NCT07362914","phase":"PHASE3","title":"Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-03-07","conditions":"Breast Cancer","enrollment":182},{"nctId":"NCT05070247","phase":"PHASE1, PHASE2","title":"A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors","status":"TERMINATED","sponsor":"Takeda","startDate":"2022-04-14","conditions":"Pancreatic Cancer, Hepatocellular Cancer, Mesothelioma","enrollment":61},{"nctId":"NCT02718833","phase":"PHASE2","title":"A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2016-06-21","conditions":"Multiple Myeloma","enrollment":52},{"nctId":"NCT05922501","phase":"PHASE2","title":"Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-05-31","conditions":"Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma","enrollment":50},{"nctId":"NCT03366155","phase":"PHASE2","title":"Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-06-24","conditions":"Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma","enrollment":24},{"nctId":"NCT06639659","phase":"NA","title":"Sphenopalatine Block vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zagazig University","startDate":"2024-10-01","conditions":"Sphenopalatine Ganglion Nerve Block, Transnasal Endoscopic Pitutary Surgery","enrollment":69},{"nctId":"NCT01665794","phase":"PHASE1, PHASE2","title":"Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2012-08-13","conditions":"Multiple Myeloma","enrollment":25},{"nctId":"NCT02343042","phase":"PHASE1, PHASE2","title":"Selinexor and Backbone Treatments of Multiple Myeloma Patients","status":"RECRUITING","sponsor":"Karyopharm Therapeutics Inc","startDate":"2015-10","conditions":"Multiple Myeloma","enrollment":300},{"nctId":"NCT03180736","phase":"PHASE3","title":"Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex","status":"COMPLETED","sponsor":"Stichting European Myeloma Network","startDate":"2017-06-14","conditions":"Multiple Myeloma","enrollment":304},{"nctId":"NCT07241351","phase":"PHASE2, PHASE3","title":"Dexmedetomidine as an Adjunct to Fentanyl for Term Neonates on Mechanical Ventilation","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-03-01","conditions":"Analgesia, Sedation and Analgesia, Neonatal","enrollment":40},{"nctId":"NCT04289142","phase":"PHASE4","title":"Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-12-01","conditions":"Delirium, Cognitive Dysfunction, Cognition Disorder","enrollment":2400},{"nctId":"NCT07073846","phase":"PHASE4","title":"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-10-06","conditions":"Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain, Postoperative Pain Management","enrollment":104},{"nctId":"NCT06352593","phase":"NA","title":"Intraoperative Dexmedetomidine Infusion in Endovascular Intervention for Aneurysmal Subarachnoid Hemorrhage","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-04-06","conditions":"Dexmedetomidine, Infusion, Endovascular","enrollment":90},{"nctId":"NCT04891289","phase":"PHASE2","title":"Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-05-07","conditions":"Intrahepatic Cholangiocarcinoma","enrollment":164},{"nctId":"NCT05911321","phase":"PHASE2","title":"Isa-Pom-Dex in Elderly/Frail Subjects With RRMM","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-12-05","conditions":"Multiple Myeloma, Relapse, Refractory","enrollment":6},{"nctId":"NCT01312857","phase":"PHASE2","title":"Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2011-03-07","conditions":"Metastatic Colorectal Cancer","enrollment":75},{"nctId":"NCT04628663","phase":"NA","title":"Effects of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries","status":"RECRUITING","sponsor":"Attikon Hospital","startDate":"2021-03-20","conditions":"Intraocular Pressure","enrollment":60},{"nctId":"NCT06538584","phase":"PHASE1, PHASE2","title":"Dex +/- Caffeine Sedation in a Post-MRI Recovery in a Pediatric Population","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2024-09-09","conditions":"Enhanced Recovery After Surgery in a Pediatric Population","enrollment":100},{"nctId":"NCT04546399","phase":"PHASE2","title":"A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-12-17","conditions":"Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia","enrollment":461},{"nctId":"NCT06259565","phase":"PHASE3","title":"Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults","status":"RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2025-07-29","conditions":"Non-Invasive Ventilation","enrollment":846},{"nctId":"NCT05581485","phase":"NA","title":"Dex vs SLNB in Spontaneous Breathing Via THRIVE for Laryngeal Surgery","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2022-11-29","conditions":"Endoscopic Laryngeal Surgery","enrollment":46},{"nctId":"NCT02310321","phase":"PHASE1, PHASE2","title":"A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2015-02-26","conditions":"Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia","enrollment":97},{"nctId":"NCT07145814","phase":"NA","title":"Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery","status":"COMPLETED","sponsor":"People's Hospital of Guangxi Zhuang Autonomous Region","startDate":"2018-01-05","conditions":"Acute Lung Injury(ALI)","enrollment":60},{"nctId":"NCT04862585","phase":"PHASE2, PHASE3","title":"Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2021-10-07","conditions":"Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8","enrollment":130},{"nctId":"NCT07034898","phase":"PHASE4","title":"Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Airway Stress Response","enrollment":60},{"nctId":"NCT01998971","phase":"PHASE1","title":"A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-02-18","conditions":"Multiple Myeloma","enrollment":240},{"nctId":"NCT04251715","phase":"PHASE2","title":"mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2021-04-28","conditions":"Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8","enrollment":5},{"nctId":"NCT06671327","phase":"PHASE4","title":"Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain","status":"NOT_YET_RECRUITING","sponsor":"China International Neuroscience Institution","startDate":"2025-04-03","conditions":"Pain Management, Noncardiac Surgery","enrollment":208},{"nctId":"NCT00059930","phase":"PHASE1","title":"Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-01","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":38},{"nctId":"NCT01862315","phase":"PHASE2","title":"Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-05","conditions":"Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma, Cholangiolar Carcinoma","enrollment":55},{"nctId":"NCT03544281","phase":"PHASE1, PHASE2","title":"To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-09-20","conditions":"Multiple Myeloma","enrollment":153},{"nctId":"NCT05168280","phase":"NA","title":"Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium in Elderly Patients","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2022-07-18","conditions":"Dexmedetomidine, Postoperative Delirium","enrollment":420},{"nctId":"NCT06848595","phase":"PHASE3","title":"Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2025-02-23","conditions":"Cerebral Desaturation Events, Spine Surgeries","enrollment":90},{"nctId":"NCT04700176","phase":"PHASE2","title":"A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma","status":"TERMINATED","sponsor":"Hackensack Meridian Health","startDate":"2022-05-02","conditions":"Multiple Myeloma","enrollment":1},{"nctId":"NCT06164314","phase":"NA","title":"Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Postoperative Delirium","enrollment":366},{"nctId":"NCT05195034","phase":"NA","title":"Effect of Dexmedetomidine on Postoperative Delirium After Awake Craniotomies","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2022-03-31","conditions":"Dexmedetomidine, Delirium, Awake Craniotomy","enrollment":210},{"nctId":"NCT03480061","phase":"PHASE4","title":"Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2018-08-09","conditions":"Delirium, Postoperative Cognitive Dysfunction, Dexmedetomidine","enrollment":90},{"nctId":"NCT00410956","phase":"PHASE2","title":"Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2007-05-09","conditions":"Liver Cancer","enrollment":22},{"nctId":"NCT05249153","phase":"NA","title":"Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-09-23","conditions":"Dexmedetomidine","enrollment":84},{"nctId":"NCT04364945","phase":"NA","title":"Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/behavioral Assessment Results in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2020-06-17","conditions":"Anesthesia and Neurotoxicity","enrollment":400},{"nctId":"NCT04878510","phase":"PHASE3","title":"Non-invasive Ventilation and Dex in Critically Ill Adults","status":"COMPLETED","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2022-03-07","conditions":"Respiratory Insufficiency","enrollment":24},{"nctId":"NCT03355053","phase":"PHASE2","title":"Investigation of Sleep in the Intensive Care Unit","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-05-29","conditions":"Delirium, Sleep","enrollment":522},{"nctId":"NCT03289325","phase":"NA","title":"Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2021-10-21","conditions":"Cardiac Surgery, Dexmedetomidine, Long-term Outcome","enrollment":285},{"nctId":"NCT01171807","phase":"PHASE2","title":"Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis","status":"COMPLETED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2003-07-22","conditions":"Ulcerative Colitis","enrollment":33},{"nctId":"NCT06607861","phase":"EARLY_PHASE1","title":"Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective Cesarean Section Under Spinal Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"Minia University","startDate":"2024-10-01","conditions":"Pain Score (VAS)","enrollment":114},{"nctId":"NCT03793751","phase":"PHASE4","title":"Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction","status":"COMPLETED","sponsor":"Tata Main Hospital","startDate":"2017-10-01","conditions":"Cognitive Dysfunction","enrollment":120},{"nctId":"NCT03413800","phase":"PHASE2","title":"Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2018-02-12","conditions":"Relapsed Hematologic Malignancy, Multiple Myeloma","enrollment":10},{"nctId":"NCT06543563","phase":"NA","title":"Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-08-09","conditions":"PD - Parkinson's Disease, Deep Brain Stimulation, Esketamine","enrollment":102},{"nctId":"NCT05550714","phase":"NA","title":"Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2022-10-15","conditions":"PD - Parkinson's Disease, Dexmedetomidine, Desflurane","enrollment":188},{"nctId":"NCT05050305","phase":"PHASE2","title":"Marizomib Central Nervous System (CNS)","status":"WITHDRAWN","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-03","conditions":"Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory","enrollment":""},{"nctId":"NCT01277289","phase":"PHASE3","title":"Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease","status":"TERMINATED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2009-06-03","conditions":"Crohn's Disease","enrollment":51},{"nctId":"NCT06434428","phase":"","title":"Comparison Between Intranasal vs Intravenous Dexmedetomidine for EEG Sedation of Children With Behavior Disorders.","status":"COMPLETED","sponsor":"Azienda Ospedaliera di Padova","startDate":"2018-03-01","conditions":"Sedation Complication","enrollment":48},{"nctId":"NCT03234972","phase":"PHASE3","title":"A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-30","conditions":"Multiple Myeloma","enrollment":213},{"nctId":"NCT02952222","phase":"PHASE4","title":"The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy","status":"COMPLETED","sponsor":"Keira Mason","startDate":"2018-05-11","conditions":"Anesthesia","enrollment":39},{"nctId":"NCT05935293","phase":"PHASE4","title":"Dexmedetomidine and Kidney Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Eduardo Schiffer","startDate":"2024-12-01","conditions":"Renal Transplantation, Dexmedetomidine","enrollment":206},{"nctId":"NCT06403670","phase":"PHASE4","title":"Dexmedetomidine and Remifentanil in NORA","status":"COMPLETED","sponsor":"Baskent University Ankara Hospital","startDate":"2022-12-17","conditions":"Comparison of the Effects of Remifentanil and Dexmedetomidine","enrollment":76},{"nctId":"NCT04798482","phase":"PHASE4","title":"Effect of Dexmedetomidine of Gastrointestinal Motility","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2021-09-14","conditions":"Anesthesia","enrollment":22},{"nctId":"NCT06090955","phase":"NA","title":"Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2023-10-25","conditions":"Delirium, Postoperative","enrollment":108},{"nctId":"NCT03450057","phase":"PHASE2","title":"Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment","status":"COMPLETED","sponsor":"Hellenic Society of Hematology","startDate":"2018-02-15","conditions":"Relapsed/Refractory Multiple Myeloma","enrollment":38},{"nctId":"NCT06302998","phase":"PHASE2","title":"Dexmedetomidine and Vasopressin in Septic Shock","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2024-06","conditions":"Sepsis, Septic Shock","enrollment":260},{"nctId":"NCT06097169","phase":"","title":"Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment","status":"COMPLETED","sponsor":"Medipol University","startDate":"2023-10-10","conditions":"Anxiety, Postoperative Pain, Nausea","enrollment":80},{"nctId":"NCT03151811","phase":"PHASE3","title":"A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide","status":"TERMINATED","sponsor":"Oncopeptides AB","startDate":"2017-06-12","conditions":"Multiple Myeloma","enrollment":495},{"nctId":"NCT06186895","phase":"NA","title":"Dexmedetomidine Versus Fentanyl on Postoperative Analgesic Profile in Laparoscopic Sleeve Gastrectomy","status":"COMPLETED","sponsor":"Helwan University","startDate":"2021-07-20","conditions":"Pain, Postoperative","enrollment":64},{"nctId":"NCT05986942","phase":"","title":"Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy","status":"COMPLETED","sponsor":"Burak Omur","startDate":"2023-10-09","conditions":"Anxiety, Postoperative Pain, Bleeding","enrollment":80},{"nctId":"NCT05462938","phase":"NA","title":"Conscious Sedation for Transcatheter Aortic Valve Implantation","status":"UNKNOWN","sponsor":"University of Ioannina","startDate":"2021-11-11","conditions":"Renal Function Disorder, Postoperative Delirium, Adverse Event","enrollment":40},{"nctId":"NCT04827056","phase":"PHASE1","title":"Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study","status":"COMPLETED","sponsor":"Pharmacotherapies for Alcohol and Substance Use Disorders Alliance","startDate":"2021-11-09","conditions":"Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)","enrollment":10},{"nctId":"NCT06076668","phase":"NA","title":"Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Delirium","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-10-16","conditions":"Dexmedetomidine, Melatonin, Delirium","enrollment":90},{"nctId":"NCT02685826","phase":"PHASE1, PHASE2","title":"A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","sponsor":"Celgene","startDate":"2016-04-25","conditions":"Multiple Myeloma","enrollment":56},{"nctId":"NCT05579964","phase":"PHASE2, PHASE3","title":"The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot","status":"COMPLETED","sponsor":"National Cardiovascular Center Harapan Kita Hospital Indonesia","startDate":"2022-10-10","conditions":"Congenital Heart Disease in Children, Cardiopulmonary Bypass, Tetralogy of Fallot","enrollment":66},{"nctId":"NCT06005363","phase":"NA","title":"CSF Metabolomics and Glymphatic Function in Patients Receiving VP- Shunt Surgery.","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-07-01","conditions":"The Association of Postoperative Cognitive Dysfunction With Glymphatic Function and Neuroinflammation, The Association of Postoperative Cognitive Dysfunction With CSF Metabolomic Change","enrollment":48},{"nctId":"NCT04561180","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"Evergreen Therapeutics, Inc.","startDate":"2022-03-04","conditions":"COVID-19 Pneumonia","enrollment":""},{"nctId":"NCT03664037","phase":"PHASE4","title":"Dexamethasone Blunts the Hypotensive Effect of Spinal Anesthesia in Geriatric Patients Undergoing Lower Limb Orthopedic Surgeries","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-03-01","conditions":"Hypotension","enrollment":110},{"nctId":"NCT04649060","phase":"PHASE3","title":"Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma","status":"TERMINATED","sponsor":"Oncopeptides AB","startDate":"2020-12-21","conditions":"Relapsed Multiple Myeloma, Relapsed-Refractory Multiple Myeloma","enrollment":54},{"nctId":"NCT05283083","phase":"PHASE2","title":"Decatecholaminisation of Septic Shock With Dexmedetomidine and In-hospital Mortality","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2022-03-25","conditions":"Septic Shock, Sepsis","enrollment":90},{"nctId":"NCT02409810","phase":"PHASE1, PHASE2","title":"Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2015-04","conditions":"Anxiety, Burns","enrollment":20},{"nctId":"NCT00005596","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-04","conditions":"Leukemia","enrollment":1076},{"nctId":"NCT05785689","phase":"PHASE4","title":"Autonomous Nervous System Regulated Paediatric Anaesthesia With Dexmedetomidine or Placebo","status":"UNKNOWN","sponsor":"University of Southern Denmark","startDate":"2023-04-01","conditions":"Postoperative Confusion, Postoperative Delirium, Postoperative Pain, Acute","enrollment":220},{"nctId":"NCT00587067","phase":"PHASE2","title":"A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-06","conditions":"Hepatic Cancer","enrollment":34},{"nctId":"NCT05340725","phase":"PHASE2, PHASE3","title":"Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-05-01","conditions":"Postoperative Pain","enrollment":45},{"nctId":"NCT01005914","phase":"PHASE2","title":"Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2009-06","conditions":"Leukemia","enrollment":11},{"nctId":"NCT05661227","phase":"NA","title":"Mechanism of Cardiac and Cerebral Function Injury Caused by Intraoperative Limb Ischemia-reperfusion","status":"UNKNOWN","sponsor":"Hebei Medical University Third Hospital","startDate":"2023-01-01","conditions":"Ischemic Reperfusion Injury","enrollment":120},{"nctId":"NCT03481556","phase":"PHASE1, PHASE2","title":"Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM","status":"TERMINATED","sponsor":"Oncopeptides AB","startDate":"2018-04-12","conditions":"Multiple Myeloma","enrollment":56},{"nctId":"NCT03651128","phase":"PHASE3","title":"Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celgene","startDate":"2019-04-16","conditions":"Multiple Myeloma","enrollment":381},{"nctId":"NCT05636566","phase":"PHASE2, PHASE3","title":"Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-02-15","conditions":"Invasive Cancer, Pediatric Cancer","enrollment":60},{"nctId":"NCT04237792","phase":"PHASE4","title":"Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-02-18","conditions":"MRI Sedation","enrollment":128},{"nctId":"NCT05226325","phase":"NA","title":"Dexmedetomidine Different Doses as Adjuvant to Entropy-assisted General Anesthesia During Functional Endoscopy Sinus Surgery.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-02-15","conditions":"Pain Management, Dexmedetomidine, Anesthesia","enrollment":99},{"nctId":"NCT05567523","phase":"PHASE4","title":"Safety Study of Dexmedetomidine in Elderly Under General Anesthesia","status":"COMPLETED","sponsor":"Zhenjiang First People's Hospital","startDate":"2019-06-01","conditions":"Hip Fractures, Hip Disease","enrollment":200},{"nctId":"NCT05577871","phase":"NA","title":"Dexmedetomidine in Off Pump Coronary Artery Bypass Grafting","status":"UNKNOWN","sponsor":"Suez Canal University","startDate":"2022-11-01","conditions":"Coronary Artery Disease","enrollment":36},{"nctId":"NCT05300802","phase":"PHASE2, PHASE3","title":"The Role of Dexmedetomidine As Myocardial Protection In Pediatric Cyanotic Congenital Heart Disease Undergoing Open Cardiac Surgery Using Cardiopulmonary Bypass Machine: A Preliminary Study","status":"COMPLETED","sponsor":"National Cardiovascular Center Harapan Kita Hospital Indonesia","startDate":"2021-12-16","conditions":"Congenital Heart Disease in Children, Cardiopulmonary Bypass","enrollment":15},{"nctId":"NCT05369949","phase":"PHASE4","title":"DEX vs SEVO in Congenital Heart Surgery","status":"NOT_YET_RECRUITING","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2023-01-05","conditions":"Heart Defects, Congenital","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":116,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Dex infusion","genericName":"Dex infusion","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone infusion delivers a corticosteroid systemically to reduce inflammation and suppress immune responses. Used for Acute inflammation and immune suppression (specific indications not detailed in available information).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}